1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on World Economy 18
2.1.2 Impact of COVID-19 on the Market 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porters Fiver Forces Analysis 36
3 Segmentation of North America Market by Onychomycosis Type 40
3.1 Market Overview by Onychomycosis Type 40
3.2 Distal Subungual Onychomycosis 42
3.3 White Superficial Onychomycosis 43
3.4 Proximal Subungual Onychomycosis 44
3.5 Candidal Onychomycosis 45
3.6 Other Onychomycosis Types 46
4 Segmentation of North America Market by Treatment Type 47
4.1 Market Overview by Treatment Type 47
4.2 Drug Treatment 49
4.3 Laser Therapy 50
4.4 Photodynamic Therapy 51
4.5 Other Therapies 52
5 Segmentation of North America Market by Distribution Channel 53
5.1 Market Overview by Distribution Channel 53
5.2 Hospitals and Clinics 55
5.3 Online Stores 56
5.4 Retail Pharmacies 57
5.5 Other Distribution Channels 58
6 North America Market 2021-2031 by Country 59
6.1 Overview of North America Market 59
6.2 U.S. 62
6.3 Canada 65
6.4 Mexico 67
7 Competitive Landscape 69
7.1 Overview of Key Vendors 69
7.2 New Product Launch, Partnership, Investment, and M&A 72
7.3 Company Profiles 73
Bausch Health Companies Inc. 73
Bayer AG 75
Cipla Ltd 76
Dr. Reddys Laboratories Ltd 77
Galderma SA 78
GlaxoSmithKline PLC 79
Johnson & Johnson 80
Lumenis Ltd 81
Medimetriks Pharmaceuticals Inc. 82
Moberg Pharma AB 83
Novartis AG 84
Pfizer Inc. 85
Sanofi SA 86
RELATED REPORTS 87